» Authors » Stephen R Kraus

Stephen R Kraus

Explore the profile of Stephen R Kraus including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 64
Citations 2153
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Winters J, Dmochowski R, Goldman H, Herndon C, Kobashi K, Kraus S, et al.
J Urol . 2012 Oct; 188(6 Suppl):2464-72. PMID: 23098783
Purpose: The authors of this guideline reviewed the literature regarding use of urodynamic testing in common lower urinary tract symptoms. The findings are intended to assist clinicians in the appropriate...
22.
Albo M, Litman H, Richter H, Lemack G, Sirls L, Chai T, et al.
J Urol . 2012 Oct; 188(6):2281-7. PMID: 23083653
Purpose: Longer term comparative efficacy information regarding transobturator and retropubic mid urethral slings is needed. We report 24-month continence rates, complications and symptom outcomes from a randomized equivalence trial. Materials...
23.
Sirls L, Tennstedt S, Lukacz E, Rickey L, Kraus S, Markland A, et al.
Female Pelvic Med Reconstr Surg . 2012 Sep; 18(5):291-5. PMID: 22983273
Aims: To compare quality of life (QoL) and factors associated with QoL change after retropubic (RMUS) and transobturator midurethral slings (TMUS) using the Incontinence Impact Questionnaire (IIQ) and the International...
24.
Sirls L, Richter H, Litman H, Kenton K, Lemack G, Lukacz E, et al.
J Urol . 2012 Sep; 189(1):204-9. PMID: 22982425
Purpose: We evaluated the influence of preoperative urodynamic studies on diagnoses, global treatment plans and outcomes in women treated with surgery for uncomplicated stress predominant urinary incontinence. Materials And Methods:...
25.
DuBeau C, Morrow J, Kraus S, Creanga D, Bavendam T
Neurourol Urodyn . 2012 Aug; 31(8):1258-65. PMID: 22907761
Aims: To assess the efficacy and tolerability of fesoterodine 8 mg versus tolterodine extended release (ER) 4 mg in subjects with overactive bladder (OAB) stratified by age (<65, 65-74, and...
26.
Richter H, Brubaker L, Stoddard A, Xu Y, Zyczynski H, Norton P, et al.
J Urol . 2012 Jun; 188(2):485-9. PMID: 22704099
Purpose: We examined preoperative and postoperative patient related factors associated with continence status up to 7 years after surgery for stress urinary incontinence. Materials And Methods: Women randomized to Burch...
27.
Nager C, Brubaker L, Litman H, Zyczynski H, Varner R, Amundsen C, et al.
N Engl J Med . 2012 May; 366(21):1987-97. PMID: 22551104
Background: Urodynamic studies are commonly performed in women before surgery for stress urinary incontinence, but there is no good evidence that they improve outcomes. Methods: We performed a multicenter, randomized,...
28.
Huang A, Hess R, Arya L, Richter H, Subak L, Bradley C, et al.
Am J Obstet Gynecol . 2012 May; 206(5):444.e1-11. PMID: 22542122
Objective: The purpose of this study was to evaluate clinical outcomes associated with the initiation of treatment for urgency-predominant incontinence in women diagnosed by a simple 3-item questionnaire. Study Design:...
29.
Fitzgerald M, DuBeau C, Kraus S, Johnson Jr H, Rahn D, Mallett V, et al.
Female Pelvic Med Reconstr Surg . 2012 Mar; 17(5):231-7. PMID: 22453106
Objectives: : This study aimed to determine whether expectations of treatment outcomes in women participating in a drug and behavioral treatment trial for urge urinary incontinence are related to patient...
30.
Sand P, Heesakkers J, Kraus S, Carlsson M, Guan Z, Berriman S
Drugs Aging . 2012 Jan; 29(2):119-31. PMID: 22276958
Background: Previous work has demonstrated the efficacy and safety of fesoterodine in older and younger subjects with overactive bladder (OAB) symptoms. The effect of long-term fesoterodine treatment in different age...